Skip to main content
Equibles

Inderjote Kathuria

Ocean Biomedical, Inc. (OCEA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ocean Biomedical, Inc. publishes a filing, an earnings call transcript or a press release.

Get OCEA alerts

About Inderjote Kathuria

Ocean Biomedical, Inc. reported in an 8-K filed February 15, 2023 that Inderjote Kathuria was appointed Chief Strategy Officer. Ocean Biomedical, Inc. reported in an 8-K filed February 15, 2023 that Inderjote Kathuria was appointed Chief Strategy Officer, effective February 14, 2023. The proxy statement of Ocean Biomedical, Inc. reports total compensation of $1,135,260 for Inderjote Kathuria in fiscal 2021. Disclosed compensation is on record for 2 fiscal years. Ocean Biomedical, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ocean Biomedical, Inc. includes M. Michelle Berrey (CEO), Michelle Berrey (CEO and Board Member), Chirinjeev Kathuria (Chairman) and 7 others.

“Effective upon the Closing, the following persons were appointed as executive officers and directors of the Company.”
Ocean Biomedical, Inc. Form 8-K, filed February 15, 2023 · Read the filing
“Effective upon the Closing, the following persons were appointed as executive officers and directors of the Company.”
Ocean Biomedical, Inc. Form 8-K, filed February 15, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Ocean Biomedical, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Ocean Biomedical, Inc. (OCEA) — $1,135,260
2020 Ocean Biomedical, Inc. (OCEA) — —

Recent activity